INTELLIGENT DECISION SYSTEMS INC
S-3/A, 1996-05-30
PREPACKAGED SOFTWARE
Previous: CUSTOM CHROME INC /DE, 10-K/A, 1996-05-30
Next: SMITH BREEDEN SERIES FUND, N-30D, 1996-05-30



 
    As filed with the Securities and Exchange Commission on May 30, 1996
                                          Registration No. 333-3437


                      SECURITIES AND EXCHANGE COMMISSION
                             Washington D.C. 20549
                              AMENDMENT NO. 1 TO
                                  FORM S-3/A
            Registration Statement Under The Securities Act of 1933

                      INTELLIGENT DECISION SYSTEMS, INC.,
                   (Successor to Resource Finance Group, Ltd.)
            (Exact name of registrant as specified in its charter)

            Delaware                             38-3286374
      (State or other jurisdiction of            (I.R.S. Employer
      incorporation or organization)             Identification No.)

                         2025 East Beltline Avenue SE
                                   Suite 400
                         Grand Rapids, Michigan 49546
                                (616) 285-5830
              (Address, including zip code, and telephone number,
       including area code, of registrant's principal executive offices)

                                 Mark A. Babin
                                   President
                      Intelligent Decision Systems, Inc.
                    2025 East Beltline Avenue SE, Suite 400
                         Grand Rapids, Michigan 49546
                                (616) 285-5830

           (Name, address, including zip code, and telephone number,
                  including area code, of agent for service)

                                  Copies to:

                          Joseph P. Richardson, Esq.
                              Brown & Bain, P.A.
                           2901 North Central Avenue
                                  Suite 2000
                            Phoenix, Arizona  85012
                                (602) 351-8000

Approximate  date  of  commencement  of  proposed  sale  to  public:  As soon as
practicable after the Registration Statement becomes effective.

If the only securities  being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. ___

If any of the  securities  being  registered on this Form are to be offered on a
delayed or continuous  basis  pursuant to Rule 415 under the  Securities  Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. _x_

If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the  Securities  Act  registration  statement  number of the  earlier  effective
registration statement for the same offering. ___

If this Form is a  post-effective  amendment filed pursuant to Rule 462(b) under
the  Securities  Act,  check  the  following  box and  list the  Securities  Act
registration  statement number of the earlier effective  registration  statement
for the same offering. ___

If delivery  of the  prospectus  is  expected  to be made  pursuant to Rule 434,
please check the following box.  ___



<PAGE>






<TABLE>
<CAPTION>
                                       CALCULATION OF REGISTRATION FEE
                                                   Proposed        Proposed
                                   Amount           Maximum         Maximum            Amount
   Title of Each Class              to be       Offering Price     Aggregate             of
of Securities to Be Registered    Registered        Per Unit     Offering Price    Registration Fee
<S>                               <C>                <C>         <C>                 <C>

Common Stock, $.001 par value     1,964,154 shares   $2.19       $4,301,497 (1)      $1,484.00 (2)

Common Stock, $.001 par value       136,654 shares   $3.75       $512,453 (3)        $  177.00 (4)
                                  ================   =====       ==========          ========= 
</TABLE>


  

     (1) The  registration  fee has been calculated  based on the average of the
high "asked" and low "bid" prices of the Common Stock on May 6, 1996 as reported
in the  over-the-counter  market on the "OTC Electronic Bulletin Board" pursuant
to Rule 457(c).

     (2) This  registration  fee was previously  paid by the registrant with the
registration Statement on Form S-3 filed with the Commission of May 10, 1996.

     (3) The  registration  fee("New  Fee")  has  been  calculated  based on the
average of the high  "asked" and low "bid" prices of the Common Stock on May 28,
1996 as reported in the over-the-counter  market on the "OTC Electronic Bulletin
Board" pursuant to Rule 457(c).

     (4) The New Fee is being  paid  with  Amendment  No. 1 to the  Registration
Statement on Form S-3/A filed with the Commission on May 30, 1996.



The Registrant hereby amends this  Registration  Statement on such date or dates
as may be necessary to delay its effective date until the Registrant  shall file
a further amendment which specifically  states that this Registration  Statement
shall  thereafter  become  effective  in  accordance  with  Section  8(a) of the
Securities  Act of  1933 or  until  this  Registration  Statement  shall  become
effective on such date as the Commission,  acting pursuant to said Section 8(a),
may determine.



                                      ii

<PAGE>



                  SUBJECT TO COMPLETION; DATED MAY 30, 1996

   Information  contained  herein is  subject  to  completion  or  amendment.  A
   registration  statement  relating to these securities has been filed with the
   Securities and Exchange Commission.  These securities may not be sold nor may
   offers  to buy be  accepted  prior  to the time  the  registration  statement
   becomes  effective.  This prospectus shall not constitute an offer to sell or
   the  solicitation  of an  offer to buy nor  shall  there be any sale of these
   securities  in any State in which such offer,  solicitation  or sale would be
   unlawful prior to registration or qualification under the securities laws of
   any such State.

                     INTELLIGENT DECISION SYSTEMS, INC.
                                 PROSPECTUS
                         FOR UP TO 1,964,154 SHARES
                              OF COMMON STOCK

   This  Prospectus  relates to up to 1,964,154  shares (the "Shares") of Common
Stock,  par value  $.001 per share  ("Common  Stock")  of  Intelligent  Decision
Systems,  Inc., a Delaware  corporation ( "IDS"), which may be offered from time
to  time  by  certain   stockholders   of  IDS  named   herein   (the   "Selling
Stockholders").  The Shares are  issuable  by IDS upon the  exercise  of certain
warrants or options to purchase  shares of Common Stock as more fully  described
below (the  "Warrants").  IDS will not receive any proceeds from the sale of the
Shares,  with the  exception  of the exercise  price of such  Warrants as may be
exercised. See "Selling Stockholders."

   IDS has been  advised by each Selling  Stockholder  that he or she expects to
offer his or her Shares through brokers and dealers to be selected by him or her
from time to time.  The Shares may be offered  for sale in the  over-the-counter
market, in one or more private transactions, or a combination of such methods of
sale, at prices and on terms then prevailing,  at prices related to such prices,
or at negotiated  prices.  Certain of the Selling  Stockholders  may  distribute
their shares,  from time to time, to their limited and/or  general  partners who
may sell Shares pursuant to this Prospectus. Each Selling Stockholder may pledge
all or a  portion  of the  Shares  owned  by him or her as  collateral  in  loan
transactions.  Upon default by such a Selling  Stockholder,  the pledgee in such
loan transaction  would have the same rights of sale as the Selling  Stockholder
under this Prospectus.  Each Selling  Stockholder may also transfer Shares owned
by him by gift and upon any such  transfer  the donee would have the same rights
of sale as such Selling  Stockholder  under this  Prospectus.  In addition,  any
securities  covered by this  Prospectus  which qualify for sale pursuant to Rule
144 of the Securities  Act of 1933, as amended (the  "Securities  Act"),  may be
sold under Rule 144 rather  than  pursuant  to this  Prospectus.  Finally,  each
Selling Stockholder and any brokers and dealers through whom sales of the Shares
are made may be deemed to be "underwriters" within the meaning of the Securities
Act,  and the  commissions  or  discounts  and other  compensation  paid to such
persons may be regarded as underwriters' compensation.

   The Common  Stock is traded under the symbol  "IDSI" in the  over-the-counter
market  on  the  "OTC  Electronic   Bulletin  Board" operated  by  the  National
Association of Securities  Dealers,  Inc. (the "OTC Bulletin Board"). On May 28,
1996, the low "bid" and high "asked" prices for the Common Stock were $3-5/8 and
$3-7/8,  respectively.  There is no  established  market for the  Warrants.  See
"Price Range of Common Stock."

   Investment in the shares  offered  hereby  involve a high degree of risk. See
"Risk Factors" which begin on page 2 of this Prospectus.

   THESE  SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR AS THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES  COMMISSION PASSED UPON THE ACCURACY
OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.

                             -----------------


             The date of this Prospectus is _______________, 1996.

                                    iii

<PAGE>



                             AVAILABLE INFORMATION


   IDS is subject to the informational  requirements of the Securities  Exchange
Act of 1934, as amended (the  "Exchange  Act"),  and, in  accordance  therewith,
files reports,  proxy  statements and other  information with the Securities and
Exchange Commission (the "Commission"). Such reports, proxy statements and other
information  can be inspected and copies thereof may be obtained,  at prescribed
rates, at the public  reference  facilities  maintained by the Commission at the
Public Reference Section,  Room 1024, 450 Fifth Street, N.W.,  Washington,  D.C.
20549, and at the Commission's Regional Offices located at 7 World Trade Center,
13th Floor,  New York,  New York 10048,  and Citicorp  Center,  500 West Madison
Street, Suite 1400, Chicago, Illinois 60661-2511. Copies of such material can be
obtained at prescribed rates by writing to the Public  Reference  Section of the
Commission at 450 Fifth Street, N.W., Washington, D.C. 20549.

   IDS has filed a  Registration  Statement on Form S-3 under the Securities Act
covering the Common Stock included in this Prospectus.  This Prospectus does not
contain  all  the  information  set  forth  in or  annexed  as  exhibits  to the
Registration Statement filed by IDS with the Commission and reference is made to
such  Registration  Statement  and the exhibits  thereto for the  complete  text
thereof.  For further information with respect to IDS and the securities offered
hereby, reference is made to the Registration Statement,  including the exhibits
filed as part thereof,  copies of which may be obtained at prescribed rates upon
request to the Commission in Washington,  D.C. Any statements  contained  herein
concerning the provisions of any documents are not necessarily complete, and, in
each instance,  such  statements are qualified in their entirety by reference to
such  document  filed as an exhibit to the  Registration  Statement or otherwise
filed with the Commission.



                                      iv

<PAGE>



              INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

   The following  documents,  which have been  previously  filed by IDS with the
Commission, are incorporated by reference in this Prospectus:

         1.    The Company's Joint Proxy Statement-Prospectus included in the
               Registration Statement on Form S-4, File No. 33-93058, as filed
               pursuant to Rule 424(b) under the Securities Act;
         2.    Annual  Report on Form 10-KSB for the fiscal year ended June 30,
               1995;
         3.    Quarterly Report on Form 10-QSB for the fiscal quarter ended
               September 30, 1995;
         4.    Quarterly Report on Form 10-QSB for the fiscal quarter ended
               December 31, 1995;
         5.    Quarterly  Report on Form 10-QSB for the fiscal quarter ended 
               March 31, 1996; and
         6.    Current Report on Form 8-K, dated April 15, 1996.


    All documents filed by IDS pursuant to Sections 13(a),  13(c), 14 or 15(d)of
the  Exchange  Act on or after  the  date of this  Prospectus  and  prior to the
termination of the offering of the Shares described herein shall be deemed to be
incorporated by reference into this  Prospectus from the respective  dates those
documents are filed.

   Any statement contained herein or in a document  incorporated or deemed to be
incorporated  by reference  herein shall be deemed to be modified or  superseded
for purposes of the  Registration  Statement  and this  Prospectus to the extent
that a statement  contained herein or in any  subsequently  filed document which
also  is or is  deemed  to be  incorporated  by  reference  herein  modifies  or
supersedes  such statement.  Any such statement so modified or superseded  shall
not be deemed, except as so modified or superseded,  to constitute a part of the
Registration Statement or this Prospectus.

   IDS  will  provide,   without  charge,  to  each  person  who  receives  this
Prospectus, upon the written or telephonic request of any such person, a copy of
any or all of the documents  which have been  incorporated  herein by reference,
other than exhibits to such  documents  (unless such  exhibits are  specifically
incorporated  by  reference).  Requests  should be  directed  in  writing to the
Secretary,  Intelligent  Decision  Systems,  Inc., 2025 East Beltline Avenue SE,
Suite 400, Grand Rapids, Michigan 49545 or by telephone at (616) 285-5830.



                                      v

<PAGE>



                                  THE COMPANY

   Intelligent  Decision  Systems,   Inc.  ("IDS")  is  a  Delaware  corporation
incorporated  on June 1, 1995 and is the  successor by a merger on April 1, 1995
with  Resource  Financial  Group,  Ltd.,  a Colorado  corporation  ("RFG").  See
"Certain  Recent   Developments."  IDS,  together  with  its  subsidiaries  (the
"Company")  develops and  distributes  computerized  business  systems  designed
specifically for the long-term  (non-acute) health care industry.  The Company's
principal  executive  offices are located at 2025 East Beltline Avenue SE, Suite
400, Grand Rapids,  Michigan 49546 and its telephone  number is (616)  285-5830.
The  Company  maintains  offices  in Draper,  Utah,  Stamford,  Connecticut  and
Scottsdale, Arizona.

                          CERTAIN RECENT DEVELOPMENTS

   IDS was originally  formed as a wholly owned subsidiary of RFG. In accordance
with the terms set forth in IDS's  Registration  Statement  on Form S-4 declared
effective by the SEC on February 9, 1996 ("Form S-4"), IDS entered into a series
of transactions whereby RFG merged with and into IDS and Digital Services, Inc.,
a Nevada  corporation ("Old DSI") merged with and into a wholly owned subsidiary
of IDS ("New DSI") on April 1, 1996 (the "Mergers").

   As a result of the Mergers,  among other things, the Company has succeeded to
the rights and obligations of RFG and Old DSI under a ten-year agreement,  dated
July 13,  1994 ("HPSI  Agreement"),  with  National  Purchasing  Corporation,  a
California  corporation  doing  business  as  HPSI  ("HPSI").  HPSI  is a  group
purchasing  organization  which presently  serves  approximately  3,000 licensed
nursing home clients,  as well as 3,000 other clients who operate principally in
the health care,  hospitality,  restaurant and institution markets.  Pursuant to
the HPSI Agreement,  the Company and HPSI have agreed to combine their expertise
and  resources   with  the  Company   developing  an   interactive,   multimedia
computerized  management  business system ("Vision System") that will provide to
system users various components,  including an order processing and confirmation
module, a vendor/supplier module, and training and installation modules and HPSI
marketing the system to its clients.  The Vision System  developed in accordance
with  the  HPSI  Agreement  will be owned by HPSI  Online,  Inc.,  a  California
corporation  and a  wholly-owned  subsidiary  of HPSI.  The business plan of the
Company will rely heavily on the success of its relationship with HPSI.

   In addition,  the Company has become a party to a Leasing Program  Agreement,
dated as of June 7, 1995 (together with Master Lease Agreement and other related
documents,  the "Leasing  Agreement")  with  Neptune  Technology  Leasing  Corp.
("Neptune") whereby Neptune will purchase the Vision System from the Company and
will lease those systems to DSI Leasing  Corporation,  a wholly owned subsidiary
of the Company,  which in turn will  sublease the Vision  System to end users of
the system. Except as provided under the Leasing Agreement,  Neptune will be the
Company's exclusive leasing source during the term of such agreement.

   The  Company is also a party to a Customer  Agreement,  a Vision  Base System
Installation  Agreement,  a Servicing  Agreement,  and other related agreements,
each  dated  March  1,  1996  with  IBM  Corporation  (collectively,   the  "IBM
Agreement"),  whereby IBM will assist the Company by providing  installation and
maintenance  and  warranty  services  for the Vision  System to end users of the
system.  IBM will provide the services on a  nationwide  basis at the  end-users
facilities which are located throughout the United States.


                                      1

<PAGE>



                                 RISK FACTORS

   The  following  factors,  in addition to those  discussed  elsewhere  in this
Prospectus,  should be carefully  considered  in evaluating an investment in the
Shares offered hereby:

Limited Liquidity and Limited Financial Resources

   The Company is  currently  spending  approximately  $200,000 per month on the
development  of its  products and its  administrative  structure  and  currently
generates cash flow of  approximately  $200,000 from the sales and rental of its
products, most significantly, those involving the Vision System. The prospective
cash flows from the Vision System  through the HPSI  Agreement are the Company's
only foreseeable material source of operational cash flow. The Company addresses
its  capital  needs  through  financing  provided  by and  Neptune  and  its own
financial  reserves,  which  are  equivalent  to  approximately  two  months  of
operating costs and expenses  (excluding non-cash items such as depreciation and
amortization).

   The Company has entered into a Loan Agreement with Neptune  pursuant to which
the Company may borrow on a revolving  basis an  aggregate  principal  amount of
$450,000.  Under this Agreement,  the Company has granted a security interest in
all of its  inventory and accounts  receivable  to Neptune.  The loan matured on
April 27, 1996 and Neptune has been  extending  credit to the Company  under the
same terms on a month-to-month basis. There can be no assurance that the Company
will be able to pay the amounts which are due under the Loan Agreement.

   The Company has sold an  aggregate  of  $1,490,000  million in the  principal
amount of its 15% Unsecured  Notes  ("Unsecured  Notes") in a private  placement
pursuant to a Note Purchase  Agreement,  dated as of December 13, 1994,  between
the Company (as the  successor to Old DSI) and each  purchaser of the  Unsecured
Notes.  The  Unsecured  Notes will mature on December 15, 1996.  There can be no
assurance  that the Company will be able to pay the amounts  which are due under
the Unsecured Notes.

     As the Company  will be unable to pay the  amounts due under the  Unsecured
Notes through the operational cash flow of the Company, the Company will need to
attract  additional  equity capital in order to repay the Unsecured  Notes.  The
ability of the Company to timely pay the  Unsecured  Notes may depend on whether
warrant  holders  of the Series A and  Series B  warrants  (together,  the "Note
Warrants")  that were issued as a Unit with the Unsecured  Notes,  exercise such
Note Warrants.  See "Selling  Stockholders."  These Note Warrants expire on July
31,  1996.  The  exercise  prices of the warrants are $2.00 (or $1.69) and $1.00
respectively.  A total of $745,000 would be contributed to equity  assuming full
exercise  of the  Series  B  Warrants  and an  additional  $1,490,000  would  be
contributed to equity assuming full exercise of the Series A Warrants. There can
be no assurances that the warrant holders will fully exercise their warrants. If
warrant holders exercise their Note Warrants,  dilution of current  shareholders
will result and the relative interests of the shareholders of the Company may be
adversely affected.

   Alternatively,  the Company could use other  available means to obtain equity
financing. Capital may be sought through additional equity offerings, as well as
collaborative  relationships,  borrowings and other available sources. There can
be no assurance that such funding will be available on acceptable  terms,  if at
all. If additional  funds are raised by issuing equity  securities,  significant
dilution  to  the  Company's  then  existing   stockholders   may  result.   The
unavailability  of such  financing  could prevent or delay the  development  and
marketing of the  Company's  products  and the  Company's  business,  results of
operation and financial condition could be materially and adversely affected.


                                      2

<PAGE>



Period of Transition

   The Company is  experiencing  a period of  transition  as it emerges from its
status as a development  stage  company.  The  transition  has placed,  and will
continue to place, a significant strain on the Company's resources.  The Company
intends to declare  itself out of the  development  stage as of July 1, 1996,  a
date that  corresponds  to the beginning of its next fiscal year. The likelihood
of  success  of the  Company  must  be  considered  in  light  of the  expenses,
difficulties and delays frequently encountered in connection with the continuing
development of a new business. If the Company is unable to manage the transition
out of the development  stage,  the Company's  business,  competitive  position,
results of operations  and financial  condition will be materially and adversely
affected.

   In addition,  the Company has recently  undergone a restructuring as a result
of the  merger of RFG with and into the  Company  and the merger of Old DSI with
New DSI, and the entire board of directors and the management  has changed.  See
"Certain  Recent   Developments."   The  Company's   ability  to  manage  growth
successfully  will  require the  personnel  of RFG and Old DSI to work  together
effectively and will require the Company to improve its operational,  management
and financial  systems and controls.  Prior to the  consummation of the Mergers,
Old DSI and RFG had been operated as separate,  independent corporations.  While
Old DSI and RFG were engaged in related  businesses  and were parties to a joint
operating  agreement  pursuant to which  certain  administrative,  financial and
other  services were  performed  cooperatively,  there can be no assurance  that
management of the Company will be able to integrate or allocate properly the two
businesses on an economic basis or be able to oversee and implement successfully
the business strategy of the Company after the Mergers. If the Company is unable
to manage this  transition  effectively,  the  Company's  business,  competitive
position,  results of operation and financial  condition  will be materially and
adversely affected.

Dependence on Collaborative Relationships

   The  Company is  reliant  on other  companies  for the  marketing,  sales and
installation of its main product,  Vision System, and accordingly,  there can be
no  assurances   that  the  Company  will  be  able  to  oversee  and  implement
successfully the business strategy of the Company.

   The Company has minimal  direct  sales or marketing  capability.  The Company
will  rely  on  HPSI  for  sales  of the  Vision  System.  See  "Certain  Recent
Developments." The failure or inability of HPSI to perform its obligations under
the HPSI Agreement or to effectively sell or market the Vision System would have
a material adverse effect on the Company.  If the Company  determines to broaden
its  business  to provide  Vision  System or other  systems to users  other than
HPSI's  clients,  the Company  will either have to develop the  capabilities  to
commercialize and market its technologies  itself or will be dependent on others
to do so. Should the Company elect to commercialize  and market its technologies
itself, the Company would need to develop additional resources, and there can be
no assurance that it will be successful in developing these capabilities.  Also,
should the Company elect to obtain additional  collaborative  partners to assist
in commercialization  and marketing its technologies and the resultant products,
there can be no  assurance  that the  Company  will be  successful  in  reaching
satisfactory arrangements with such third parties.

   The  Company's  ability to install and maintain the Vision System is limited.
The Company  relies on IBM to install and service the Vision System  pursuant to
the IBM Agreement. The failure or inability of IBM to satisfactorily perform its
obligations  under the IBM  Agreement or to  adequately  install and service the
Vision System would have a material adverse effect on the Company.


                                      3

<PAGE>



History of Losses and Expectation of Future Losses

   The Company has generated  minimum net income from operations in the past and
there can be no assurance that the Company will become profitable in the future.
The Company has an aggregate  accumulated deficit of $1,924,005 through June 30,
1995. The continuing development and commercialization of the Company's products
will  require  substantial  expenditures.  There  can be no  assurance  that the
Company's products will ever gain commercial acceptance or that the Company will
ever generate significant revenues or achieve profitability.

Dependence on the Vision System; Uncertainty of Market Acceptance

   The Vision System is currently the Company's primary product. The Company has
only sold the Vision System  product in limited  quantities  and there can be no
assurance that the Company's  continuing  efforts will be successful or that the
Vision System and any other product  developed by the Company will be effective,
capable of being  manufactured at commercial  quantities at acceptable costs, or
successfully  marketed.  The Company expects that the Vision System,  when fully
commercialized,  will account for substantially  all the Company's  earnings for
the  foreseeable  future.  Because the Vision System  currently  represents  the
Company's  main  product  focus,  if the Vision  System is not  successful,  the
Company's  business,  financial  condition  and  results of  operation  could be
materially and adversely affected.

Risk of Product Defects

   Software  products  as complex as those  offered by the  Company  may contain
defects or failures  when  introduced  or when new  versions are  released.  The
Company may discover software defects in the Vision System or its other products
and may  experience  delays or lost  revenues  to  correct  such  defects in the
future.  Although the Company has not yet experienced significant delays or lost
revenues for any defects,  there can be no assurance that despite testing by the
Company,   errors  will  not  be  found  in  new  products  released  after  the
commencement  of  commercial  shipment,  resulting  in loss of  market  share or
failure to achieve market acceptance.  Any such occurrence could have a material
adverse  effect upon the  Company's  business,  operating  results or  financial
condition.

Products in Development

     The markets for the Company's  existing and planned  computer  software and
hardware  products are  characterized by rapidly changing  technology,  evolving
industry  standards,  frequent new product  introductions and enhancements.  The
successful development and commercialization of new products involve many risks,
including  the  identification  of new  product  opportunities,  the  successful
completion  of  the  development  process,  and  the  retention  and  hiring  of
appropriate  research and development  personnel.  The  introduction of products
embodying new  technologies  and the emergence of new industry  standards  could
render the Company's  existing products and products currently under development
obsolete  and  unmarketable.  The  Company's  future  success  will  depend upon
successfully  developing and  distributing  the Vision System in connection with
the HPSI Agreement, and thereafter upon its ability to enhance the Vision System
and to develop and  introduce  new  products  that keep pace with  technological
developments,  respond to evolving  end-user  requirements  and  achieve  market
acceptance.  Any failure by the Company to anticipate  or respond  adequately to
technological  developments or end-user requirements,  or any significant delays
in  product   development   or   introduction,   could   result  in  a  loss  of
competitiveness  or  revenues.  There  can  be no  assurance  that  products  or
technologies  developed  by others  will not render the  Company's  products  or
technologies  noncompetitive or obsolete or that the Company will not experience
significant delays in the future,  which could have a material adverse effect on
the Company's results of operations.  In addition, there can be no assurance the
Company will be successful in developing

                                      4

<PAGE>



and marketing new products or product enhancements on a timely basis or that new
products or product  enhancements  developed by the Company will achieve  market
acceptance.

   In  addition,  the life cycle of the  Company's  products  are  difficult  to
predict due to the effect of new product  introductions or product  enhancements
by the Company or to competitors,  market acceptance of new or enhanced versions
of the Company's products and competition in the Company's marketplace. Declines
in the  demand  for the  Vision  System,  whether  as a result  of  competition,
technological  change,  price  reductions  or  otherwise,  could have a material
adverse  effect on the  Company's  business,  operating  results  and  financial
condition.

Limited Production Capabilities

   The Company currently integrates various components into the Vision System in
limited  quantities  in  Draper,  Utah.  However,  the  Company  does  not  have
experience in producing the Vision System in commercial quantities.  The Company
may encounter difficulties in scaling up production of the Vision System to meet
customer demand, including problems involving production yields, quality control
and assurance, components supply and shortages of qualified personnel. There can
be no assurance that the Company will not encounter manufacturing  difficulties,
which  could  have a  material  adverse  effect on the  Company's  business  and
financial condition and results of operation. Should the Company elect to obtain
additional  collaborative  partners  to assist in  producing  Vision  Systems in
commercial  quantities,  there  can be no  assurance  that the  Company  will be
successful in reaching satisfactory arrangements with such parties.

Limited Trading Market for Common Stock

   The Common  Stock is traded in the  over-the-counter  market  through the OTC
Bulletin Board under the symbol "IDSI." Prior to the Mergers, the trading market
for the Common Stock of the Company's  predecessor,  RFG, was extremely  limited
and  sporadic.  There can be no  assurance  that an active  trading  market will
develop or be sustained.

Commercial/Consumer Acceptance of PICK Operating System

   The Company's  Screenware  software,  which is used for the Vision System, is
designed  to be  used  on a  unique  operating  system  called  PICK.  PICK is a
multi-user,  multi-tasking  operating  system  which  results  in a less  costly
investment in hardware.  In addition,  PICK's  operating system is itself a data
base  which  results  in a much  faster  system  that is  easier to use and more
user-friendly  than most other  operating  systems and  eliminates  the need for
purchasing  a third  party  database.  It is  estimated  that  nearly 80% of the
Fortune 1000 companies have PICK-based applications in their organizations.  The
Company's  products  are based on the PICK  operating  system.  Any factors that
adversely affect the availability or popularity of PICK in the market would have
a material adverse effect on the Company's  operating  system.  The Company will
have no control  over the factors  that affect the  availability  or  commercial
acceptance of the PICK operating system.

Competition

   A large  number of  companies  compete  in the  computer  software  business,
including  the  portion of the  market  targeted  at  developing  and  providing
business  management  systems in which the Company will competes.  Many of these
companies have far greater  capital,  technical,  personal,  marketing and other
resources than the Company. Furthermore, there can be no assurance that these or
other firms will not develop new or enhanced  products and software systems that
are more effective than any that have been or may be developed by the Company.

                                      5

<PAGE>



Importance of Intellectual Property

   The Company does not currently  hold any patent or copyright  protection  for
its  principal  assets.  Management  of the  Company  may file  for  appropriate
intellectual  property protection in the future but there are no assurances such
protection  will  be  granted  or that  protection  will be  adequate  to  deter
misappropriation  of the  Company's  technologies  or  that  there  will  not be
independent  third party  development  of similar  technologies.  The  Company's
success and revenues  will depend,  in part, on its ability to obtain or license
patents, protect trade secrets and operate without infringing on the proprietary
rights of others.

   The Company has not in the past adhered to a disciplined  regimen relating to
the execution of confidential disclosure, proprietary rights and non-competition
agreements with its vendors, customers, employees and consultants.  Accordingly,
there are  significant  risks that claims may be brought  against the Company in
the future for infringing on the  proprietary  rights of others.  The Company is
not aware of any actual material infringement,  and no such claims are currently
pending against the Company.

   Management  has started  taking  steps to protect the  Company's  proprietary
information.  However,  the patent and  proprietary  protection  of  software is
highly competitive and involves complex legal and factual  questions.  There can
be no  assurance  that any patents  issued to the Company  will  provide it with
competitive  advantages or will not be challenged by others, or that the patents
or  proprietary  rights of others will not have an adverse effect on the ability
of the  Company to do  business.  Furthermore,  there can be no  assurance  that
others will not independently develop similar products or, if patents are issued
to the Company,  that others will not design around such patents or  proprietary
rights.  In addition,  the Company may be required to obtain licenses to patents
or other proprietary rights of other parties. No assurance can be given that any
licenses  required  under any such patents or  proprietary  rights would be made
available on terms acceptable to the Company, if at all. If the Company does not
obtain such licenses,  it could encounter delays in product market introductions
while it  attempts  to  design  around  such  patents,  or could  find  that the
development,  manufacture  or sale of products  requiring such licenses could be
foreclosed. In addition, the Company could experience a loss of revenues as well
as incur  substantial costs in defending itself and indemnifying its partners in
suits brought  against it or one or more of them on such patents or  proprietary
rights or in suits in which the Company's  patents or proprietary  rights may be
asserted by it against  another party.  Further,  there can be no assurance that
any  patent  obtained  or  licensed  by the  Company  will  be  held  valid  and
enforceable if challenged by another party.

Dividends

   Neither the  Company  nor its  predecessor  has ever paid cash  dividends  on
shares of its Common Stock, and the Company does not intend to pay any dividends
in the foreseeable future. The Company intends to reinvest earnings,  if any, in
the development of its business.

Dependence on Key Employees

   The Company's  success will depend,  to a significant  extent, on IDS's Chief
Executive  and  Financial  Officer,  and  President,  Mark A.  Babin,  New DSI's
President,  Chief  Executive  Officer and  Treasurer,  David A. Horowitz and New
DSI's Executive Vice President,  Chief Science Officer and Secretary,  Robert B.
Hyte and on other members of its senior  management.  Mr. Hyte is the creator of
the Screenware  Software which operates on the PICK operating  system upon which
DSI's  existing  software  is based,  and upon which the  Company's  software is
based. The loss of the services of Mr. Babin, Mr. Horowitz or Mr. Hyte or any of
its other key  employees,  could have a material  adverse effect on the Company.
The  Company's  future  success  will also  depend  largely  upon its ability to
attract and retain other highly qualified  personnel.  There can be no assurance
that the Company will be successful in attracting and retaining such personnel.

                                      6

<PAGE>



Possible Volatility of Stock Price

   The market price of the Company's and its predecessor's common stock has been
volatile.  Future  announcements  concerning  the  Company  or its  competitors,
quarterly  variations  and operating  results,  announcements  of  technological
innovations,  the  introduction  of new  products or changes in product  pricing
policies by the Company or to  competitors,  litigation  relating to proprietary
rights or other litigation,  changes in earnings  estimates by analysts or other
factors   could  cause  the  market  price  of  the  Common   Stock   fluctuates
substantially.  In addition,  the stock market has from time to time experienced
significant price and volume  fluctuations  that have particularly  affected the
market price for the common stock of  technology  companies  and that have often
been unrelated to the operating performance of particular companies. These broad
market  fluctuations may also adversely affect the market price of the Company's
common stock. In certain  circumstances,  following periods of volatility in the
market price of a company's  securities,  securities class action litigation has
occurred  against such issuing  company.  There can be no  assurances  that such
litigation  will not occur in the  future  with  respect  to the  Company.  Such
litigation  could result in substantial cost and divert  management's  attention
and  resources,  which could have a material and adverse effect on the Company's
business, financial condition and results of operation.

Potential Dilution

     As a result of the  Mergers,  there are  issued and  outstanding  warrants,
options  and other  rights to acquire  up to  8,492,700  shares of Common  Stock
(including shares subject to the Series A and Series B Warrants).  Such options,
warrants and other rights are exercisable at per share prices ranging from $0.50
to $20.00,  and most are exercisable  through the year 2000. The exercise of all
or  a  material  portion  of  such  options,  warrants  or  other  rights  would
substantially  dilute the ownership  percentage of Common Stock owned by holders
of Common Stock.

SEC Investigation of Regulation S Offerings

   IDS is  being  investigated  by the  staff  of the  Securities  and  Exchange
Commission.  Management  of  IDS  believes  that  this  investigation  primarily
concerns  certain  stock  offerings  in 1994 and earlier of the Common  Stock of
IDS's  predecessor,  RFG, to  overseas  investors  made by IDS in reliance  upon
Regulation  S under the  Securities  Act,  but may  relate to other  operational
matters  as well.  Although  the  management  of IDS  believes  that IDS has not
engaged in any  wrongdoing,  there can be no assurances as to the outcome of any
such investigation.

                               USE OF PROCEEDS

   Other than the exercise  price of such of the  Warrants as may be  exercised,
the Company  will not receive  any of the  proceeds  from the sale of the Common
Stock offered hereby. The Company will pay the costs of this offering, which are
estimated to be $11,104.  Holders of the Warrants are not  obligated to exercise
their  Warrants,  and there can be no assurance that such holders will choose to
exercise all or any of such  Warrants.  The gross proceeds to the Company in the
event that all of the Warrants are exercised would be $2,561,000 (745,000 shares
at an exercise  price of $2.00 per share or 881,654  shares at an exercise price
of $1.69 per share,  745,000  shares at an exercise price of $1.00 per share and
337,500 shares at an exercise price of $1.00 per share).

   The Company  intends to apply the net proceeds it receives  from the exercise
of the  Warrants,  to the  extent  any  are  exercised,  to  discharge  existing
indebtedness  of the  Company  and to augment  its  working  capital for general
corporate purposes.


                                      7

<PAGE>



                          PRICE RANGE OF COMMON STOCK

   The Company's Common Stock has traded in the over-the-counter  market through
the "OTC Electronic Bulletin Board" (the "OTC Bulletin Board") maintained by the
National  Association  of  Securities  Dealers,  Inc.  under the symbol  "IDSI."
Trading in the Common Stock commenced on April 1, 1996,  upon the  effectiveness
of the Mergers.  Prior to April 1, 1996,  the Common Stock of IDS's  predecessor
traded  through the OTC  Bulletin  Board under the symbol  "RFGP" from April 29,
1993 through March 31, 1996.  The  following  table sets forth the range of high
bid and low ask quotations per share for the Common Stock and the  predecessor's
common stock for the periods indicated.  The quotations are inter-dealer  prices
in  the   over-the-counter   market  without  retail  mark-ups,   mark-downs  or
commissions, and may not represent actual transactions.

                               RFG COMMON STOCK

   The prices of RFG Common Stock set forth below  represent  historical  prices
which have been divided by 4 to reflect the exchange ratio used in the merger of
RFG into IDS whereby  each four shares of RFG Common  Stock  became one share of
IDS Common Stock.

         Period                  High Bid($) Low Ask($)

   Apr. 29 - June 30, 1993       1-1/4       5/8
   July 1 - Sept. 30, 1993       1-1/4       1-1/8
   Oct. 1 - Dec. 31, 1993        1-3/8       1-1/4
   Jan. 1 - Mar. 31, 1994        1-5/16      1
   Apr. 1 - June 30, 1994        1-3/16      1-1/16
   July 1 - Sept. 30, 1994       1-1/2       1-1/4
   Oct. 1 - Dec. 31, 1994        1-1/8       1-1/2
   Jan. 1 - Mar. 31, 1995        1-5/32      1-5/16
   Apr. 1 - June 30, 1995        1-5/16      1
   July 1 - Sept. 30, 1995       1/2         3/4
   Oct. 1 - Dec. 31, 1995        3/16        1/4
   Jan. 1 - March 31, 1996       1/8         1/4



                               IDS COMMON STOCK

         Period                  High Bid($) Low Ask($)

   April 1 - May 28, 1996        3-13/16     2-3/16

   As of May 28, 1996,  there were  approximately  1,750 owners of record of the
Common  Stock  and the  Company  believes  that  there are  approximately  2,300
beneficial  owners of the Common  Stock,  many of whom the Company  believes are
residents  of  countries  other  than the  United  States.  The large  number of
non-United  States resident  beneficial owners is a result of the sale of shares
of Common Stock of IDS' predecessor in private  placements outside of the United
States  pursuant to  Regulation S  promulgated  by the  Securities  and Exchange
Commission prior to its merger with IDS.


                                      8

<PAGE>



                               DIVIDEND POLICY

   The Company has never paid a cash dividend on its Common  Stock.  The Company
expects that for the foreseeable  future,  any earnings will be retained for use
in the  Company's  business  or for other  corporate  purposes,  and it does not
expect to pay any cash dividends in the foreseeable future.

                             SELLING STOCKHOLDERS

   Prior to the  Mergers,  Old DSI sold an aggregate  of  $1,490,000  million of
principal  amount of its Unsecured  Notes in a private  placement  pursuant to a
Note  Purchase  Agreement,  dated as of December  13,  1994 (the "Note  Purchase
Agreement") between Old DSI and each purchaser of the Unsecured Notes.

   In connection  with such sale, Old DSI issued to the purchasers of such notes
Series A and Series B  Warrants.  Each Series A Warrant  was  exercisable  on or
after July 31,  1995 to  purchase  10,000  shares of DSI Common  Stock  which is
subject to certain  restrictions  at a per share  price of $2.00  until July 31,
1996 (the  "Termination  Date"),  subject to certain  conditions  and subject to
adjustment  in  certain  circumstances  including  a stock  split  of,  or stock
dividend  on, or a  subdivision,  combination,  or  recapitalization  of the DSI
Common  Stock.  Each Series A Warrant  also  provided  for a special  conversion
adjustment  provision  (the  "Special  Conversion  Right")  in the event Old DSI
entered into a merger or similar transaction with RFG or any related party prior
to 18  months  from  original  issuance  date  of  such  warrants.  The  Special
Conversion  Right is a right of the  holders of the Series A Warrants to acquire
an aggregate of  approximately  fifteen percent  (assuming all Series A Warrants
are exercised) of the shares of the voting common stock of any entity  surviving
a merger with Old DSI prior to July 31, 1996.

   Each of the Series B Warrants  was  exercisable  on or after July 31, 1995 to
purchase  10,000  shares of Common Stock at a per share price of $4.00 until the
Termination Date, subject to the same adjustment provisions as are applicable to
the Series A Warrants  (except  that the Series B Warrants  do not  include  the
Special  Conversion Right). The Series B Warrants provided that in the event the
Company  fails to obtain a listing of its Common  Stock on the small cap section
of the  NASDAQ  on or before a date  which is  within  one year from the date of
original  issuance  or the Common  Stock trade below $3.20 per share at any time
during such period,  the exercise price of the Series B Warrants will be reduced
from $4.00 to $1.00 per share.

   Upon the consummation of the Mergers,  each outstanding Warrant for shares of
DSI Common  Stock was  converted  into  Warrants  to acquire  the same number of
shares  of  Common  Stock of the  Company  on the same  terms  set forth in such
Warrants.  Accordingly,  an aggregate of approximately  745,000 shares of Common
Stock are  purchasable at $2.00 per share (or 881,654 shares of Common Stock are
purchasable  at $1.69  per  share)  by  holders  of the  Series A  Warrants  and
approximately  745,000 shares of Common Stock are purchasable at $1.00 per share
by holders of Series B Warrants.

   Old DSI granted "piggy back"  registration  rights to the holders of Series A
Warrants  and Series B  Warrants  with  respect  to the  shares of common  stock
issuable  upon the exercise  thereof.  As a result of the  Mergers,  such rights
obligate the Company to use reasonable efforts to include shares of Common Stock
in any  registration  statement filed by the Company in connection with the sale
of shares of equity securities by the Company.

   On April 28,  1995,  Epoch  Resources  Inc.  received  an option to  purchase
337,500  shares of Old DSI Common  Stock at $1.00 per share in exchange  for its
existing  rights to receive Old DSI Common  Stock.  On  February 8, 1996,  Epoch
Resources Inc., requested that its option for 138,760 shares of Common Stock (of
the 337,000 shares) be transferred to Daniel Pfeiffer.


                                      9

<PAGE>



   The foregoing Warrants constitute "restricted  securities" within the meaning
of Rule 144 of the  regulations  promulgated  under the Securities Act. As such,
they generally are not currently transferable. However, the Shares issuable upon
exercise of the  Warrants,  when issued upon  exercise of the  Warrants and sold
pursuant to this Prospectus, will be currently transferable.

     The following table sets forth certain  information as of May 30, 1996 with
respect  to the  Selling  Stockholders.  The  shares  to be sold by the  Selling
Stockholders  represent  shares of Common Stock  currently  owned by the Selling
Stockholders  or which may be acquired by them on exercise  but will not receive
any of the proceeds  from the sale of such shares.  Beneficial  ownership  after
this offering will depend on the number of Shares  actually sold by each Selling
Stockholder.



                           Number of Shares of Common
                             Stock Owned by Selling      Shares of Common Stock
   Selling Stockholder             Shareholder (1)           Offered Hereby

                           Shares      % of Class      Shares     % of Class

Banque Paribas            218,343        2             218,343       2
A. David Barnes, M.D.      37,834 (2)     .4            21,834        .2
Mitchell G. Bradford IRA   23,834 (3)     .2            21,834        .2
Bernard L. Brodkorb        66,418 (4)     .6            32,752        .3
Wing Chau                  65,503         .6            65,503        .6
Dr. Yong Chung             65,503         .6            65,503        .6
Robert J. Colsen           21,834         .2            21,834        .2
Epoch Resources, Inc.     228,740 (5)    2             198,740       1
Ralph and Jean Forte       21,834         .2            21,834        .2
Herbert Friske             43,699         .4            43,669        .4
Thomas B. Fryer Sr.        87,337         .8            87,337        .8
House & Co.               218,343        2             218,343       2
Manuel Hernandez           21,834         .2            21,834        .2
Shorland G. Hunsaker      107,337 (6)    1              87,337        .8
Richard J. Jutzi           10,917         .1            10,917        .1
Richard Loomis             21,834         .2            21,834        .2
Stanley Peter Lopat, M.D.  65,503         .6            65,503        .6
Bruce T. MacMillan         83,669 (7)     .8            43,669        .4
Massinvest S.A.           109,172        1             109,172       1




                                      10

<PAGE>



Jerry Matsumura/Pomona     21,834        .2            21,834        .2
Valley
Joel S. Morse              10,917        .1            10,917        .1
Daniel Pfeiffer           138,760 (8)   1             138,760       1
Mark Scheier M.D.          26,334 (9)    .2            21,834        .2
Vicky L. Schiff            10,917        .1            10,917        .1
Robert Schneiderman        12,917 (10)   .1            10,917        .1
Omer Schrock Pension P/S   21,834        .2            21,834        .2
Sherwood Schwartz          31,834 (11)   .3            21,834        .2
Scroggie Holdings, Inc.    43,669        .4            43,669        .4
Richard L. Sears           48,469 (12)   .5            43,669        .4
Loyal A. Seeds             45,669 (13)   .4            43,669        .4
Charles Smith              43,669        .4            43,669        .4
Robinson Family Trust      22,834 (14)   .2            21,834        .2
Robert K. Torgerson        10,917        .1            10,917        .1
Robert and Audrey          10,917        .1            10,917        .1
Torgerson Trust
Victor Investments L.L.C.  40,834 (15)   .4            21,834        .2
Lakha Wahla                21,834        .2            21,834        .2
Herman O. Westover         35,834 (16)   .3            21,834        .2
Yingling Family Trust      43,669        .4            43,669        .4
- ----------------------------------

   (1)    Unless  otherwise  indicated,  includes  the  shares of IDS Common
          Stock underlying the Warrants.
   (2)    Includes an option to purchase 16,000 shares of Common Stock of IDS at
          $1.00/share; expires 2/1/00.
   (3)    Includes 2,000 shares of IDS Common Stock.
   (4)    Includes 33,668 shares of IDS Common Stock.
   (5)    Includes 30,000 shares of IDS Common Stock and an option to purchase
          198,740 shares of Common Stock of IDS at $1.00/share; expires 4/28/00.
   (6)    Includes 20,000 shares of IDS Common Stock.
   (7)    Includes 40,000 shares of IDS Common Stock.
   (8)    Includes an option to purchase 1138,760 shares of Common Stock of IDS
          at $1.00/share; expires 4/28/00.
   (9)    Includes 4,500 shares of IDS Common Stock.
   (10)   Includes 2,000 shares of IDS Common Stock.
   (11)   Includes 10,000 shares of IDS Common Stock.
   (12)   Includes 4,800 shares of IDS Common Stock.
   (13)   Includes 2,000 shares of IDS Common Stock.
   (14)   Includes 1,000 shares of IDS Common Stock.
   (15)   Includes 19,000 shares of IDS Common Stock.
   (16)   Includes 14,000 shares of IDS Common Stock.


                                     11


<PAGE>


   The sale of the shares by the Selling  Stockholders may be effected from time
to time in  transactions  (which may include  block  transactions  by or for the
account  of the  Selling  Stockholders)  in the  over-the-counter  market  or in
negotiated  transactions,  through  the  writing of options  on such  shares,  a
combination  of such methods of sale, or  otherwise.  Sales may be made at fixed
prices which may be changed, at market prices prevailing at the time of sale, or
at negotiated prices.

   Selling  Stockholders  may effect such  transactions  by selling their shares
directly to purchasers,  through broker-dealers acting as agents for the Selling
Stockholders,  or to  broker-dealers  who may purchase  shares as principals and
thereafter sell the shares from time to time in the over-the-counter  market, in
negotiated transactions, or otherwise. Such broker-dealers,  if any, may receive
compensation  in the form of discounts,  concessions,  or  commissions  from the
Selling  Stockholders and/or the purchasers for whom such broker-dealers may act
as agents or to whom they may sell as principals or both (which  compensation as
to a particular broker-dealer may be in excess of customary commissions).

   The Selling  Stockholders  and  broker-dealers,  if any, acting in connection
with  such sale  might be deemed to be  "underwriters"  within  the  meaning  of
Section 2(11) of the Securities Act and any commission  received by them and any
profit on the resale of such shares might be deemed to be underwriting discounts
and commissions under the Securities Act.

                             PLAN OF DISTRIBUTION

   The  Shares  offered  hereby  are  being  sold  by  the  respective   Selling
Stockholders  acting as principal for its own account.  The Company will receive
none of the  proceeds  from such  offering,  with the  exception of the exercise
price of such Warrants as may be exercised.

   The distribution of the Shares by the Selling  Stockholders is not subject to
any underwriting  agreement.  The Company expects that each Selling  Stockholder
will sell its shares  covered by this  Prospectus  through  customary  brokerage
channels,  either  through  broker-dealers  acting as  principals,  who may then
resell  the  Shares  in the  over-the-counter  market,  or at  private  sales or
otherwise, at market prices prevailing at the time of sale, at prices related to
such prevailing market prices or at negotiated prices.  Each Selling Stockholder
may effect such transactions by selling Shares through broker-dealers,  and such
broker-dealers  will receive  compensation  in the form of commissions  from the
Selling  Stockholders  and/or the purchasers of the Shares for whom they may act
as agent (which  compensation may be in excess of customary  commissions).  Each
Selling  Stockholder and any  broker-dealers  that participate with such Selling
Stockholder in the  distribution  of the Shares may be deemed to be underwriters
and any commission  received by such  broker-dealers and any profit on resale of
Shares sold by them might be deemed to be underwriting  discounts or commissions
under the Securities  Act. All expenses of  registration  incurred in connection
with this offering are being borne by the Company, but all brokerage commissions
and other similar expenses incurred by any Selling  Stockholder will be borne by
such Selling Stockholder.

   At the time a particular offer of Shares is made, to the extent  required,  a
supplement to this  Prospectus  will be distributed  which will identify and set
forth the  aggregate  amount of Common Stock being  offered and the terms of the
offering.

   The  Selling  Stockholders  are not  restricted  as to the price or prices at
which he or she may sell Shares.  Sales of Shares at less than market prices may
depress  the market  price of the  Company's  Common  Stock.  Moreover,  Selling
Stockholders  are not restricted as to the number of Shares which may


                                     12


<PAGE>

be sold at any one time,  and it is possible that a  significant  number of
Shares could be sold at the same time.

   Under applicable  rules and regulations  under the Exchange Act, any person
engaged in a distribution of the Common Stock may not  simultaneously  engage in
market making  activities  with respect to the Common Stock for a period of nine
business days prior to the  commencement of such  distribution.  In addition and
without  limiting the  foregoing,  the Selling  Stockholders  will be subject to
applicable  provisions  of the  Exchange  Act  and  the  rules  and  regulations
thereunder, including without limitation rules 10b-6 and 10b-7, which provisions
may limit the  timing of  purchases  and sales of the  Shares by  certain of the
Selling Stockholders.

   In order to comply with certain states'  securities laws, if applicable,  the
Shares may be sold in such  jurisdiction  only  through  registered  or licensed
brokers  or  dealers.  In certain  states the Shares may not be sold  unless the
Shares have been  registered or qualified  for sale in such state,  or unless an
exemption from registration or qualification is available and is obtained.

                                   EXPERTS

   Certain financial statements of the Company incorporated by reference in this
Prospectus  from the Company's  Form S-4 have been audited by Wilber & Townsend,
P.C.,  independent  certified public accountants,  as indicated in their reports
with respect thereto, and included herein in reliance upon the authority of said
firm as experts in auditing and accounting in giving said reports.

                                 LEGAL MATTERS

   The legality of the shares offered under the Registration  Statement of which
this  Prospectus  is a part will be passed upon for the Company by Brown & Bain,
P.A., special counsel to the Company.



                                      13

<PAGE>


    No  dealer,  salesman  or  other  person  has been  authorized  to give any
information  or make any  representations,  other than those  contained  in this
Prospectus,  in connection with the offering hereby, and, if given or made, such
information  and  representations  must  not  be  relied  upon  as  having  been
authorized by the Company or the Selling  Securityholders.  This Prospectus does
not  constitute  an offer to sell,  or a  solicitation  of an offer to buy,  any
securities to any person in any State or other  jurisdiction in which such offer
or  solicitation  is unlawful.  Neither the delivery of this  Prospectus nor any
sale made hereunder shall, under any circumstances,  create any implication that
there has been no change in the affairs of the  Company or the facts  herein set
forth since the date hereof.


                                        ----------------------------------------
                                        ----------------------------------------
                                          
                                                Shares of Common Stock



                                                  INTELLIGENT DECISION
                                                     SYSTEMS, INC.

                                                   -----------------
           TABLE OF CONTENTS

                                   Page

Available Information................iv
Incorporation of Certain Information                  PROSPECTUS
by Reference......................... v
The Company.......................... 1
Certain Recent Developments.......... 1
Risk Factors......................... 2
Use of Proceeds...................... 7            -----------------
Price Range of Common Stock ......... 8
Dividend Policy...................... 9
Selling Stockholders................. 9
Plan of Distribution.................12
Experts..............................13
Legal Matters........................13
                                                     __________, 1996





                                        ----------------------------------------
                                        ----------------------------------------








                                      14

<PAGE>



                                   PART II

                  INFORMATION NOT REQUIRED IN THE PROSPECTUS

ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

   The Company  estimates  that  expenses in  connection  with the  distribution
described  in this  Registration  Statement  will be as  follows.  All  expenses
incurred with respect to the distribution will be paid by the Company.

SEC registration fee...........................  $1,661
Printing expenses..............................     250
Accounting fees and expenses...................     120
Legal fees and expenses........................   8,000
Fees and expenses for qualification under state
securities laws ...............................   1,000
Miscellaneous..................................     250
                                                --------

   Total....................................... $11,281


ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS

   Section 145 of the  General  Corporation  Law of the State of  Delaware  (the
"Delaware  Law")  empowers a Delaware  corporation  to indemnify any persons who
are,  or are  threatened  to be made,  parties  to any  threatened,  pending  or
completed   legal  action,   suit  or  proceeding,   whether  civil,   criminal,
administrative or investigative (other than an action by or in the right of such
corporation),  by reason of the fact that such person was an officer or director
of such corporation,  or is or was serving at the request of such corporation as
a director, officer, employee or agent of another corporation or enterprise. The
indemnity may include expenses (including attorneys' fees), judgments, fines and
amounts paid in settlement  actually and  reasonably  incurred by such person in
connection with such action,  suit or proceeding,  provided that such officer or
director acted in good faith and in a manner he reasonably believed to be in, or
not opposed to, the corporation's best interests,  and for criminal proceedings,
had no  reasonable  cause  to  believe  his  conduct  was  illegal.  A  Delaware
corporation may indemnify officers and directors in an action by or in the right
of the corporation under the same conditions,  except that no indemnification is
permitted without judicial approval if the officer or director is adjudged to be
liable to the  corporation in the  performance of his duty.  Where an officer or
director is  successful  on the merits or otherwise in the defense of any action
referred to above, the corporation must indemnify him against the expenses which
such officer or directly actually and reasonably incurred.

   In accordance with the Delaware Law, the Certificate of  Incorporation of the
Company  contains a provision to limit the personal  liability of the  directors
for  violations  of  their  fiduciary  duty.  This  provision   eliminates  each
director's liability to the Company or its respective  stockholders for monetary
damages  except  (i) for any  breach of the  director's  duty of  loyalty to the
Company or its  stockholders,  (ii) for acts or  omissions  not in good faith or
which involve intentional  misconduct or a knowing violation of law, (iii) under
Section 174 of the  Delaware  Law  providing  for  liability  of  directors  for
unlawful  payment of dividends or unlawful stock  purchases or  redemptions,  or
(iv) for any  transaction  from which a director  derived an  improper  personal
benefit.  The effect of this provision is to eliminate the personal liability of
directors for monetary damages for actions involving a breach of their fiduciary
duty of care, including any such actions involving gross negligence.

                                     II-1

<PAGE>



   Section 6.4 of the By-Laws of the Company  provides  for  indemnification  of
directors, officers and employees as follows:

                                 ARTICLE VIII

                               INDEMNIFICATION

   Each Director and officer of the Corporation now or hereafter serving as such
shall  be  indemnified  by the  Corporation  against  any  and  all  claims  and
liabilities to which he or she has or may become subject by reason or serving or
having served as such Director or officer, or by reason of any action alleged to
have  been  taken,  omitted,  neglected  as such  Director  or  officer  and the
Corporation  shall reimburse each such person for all legal expenses  reasonably
incurred in connection  with any such claim or liability or wrong  payments made
by him or her in satisfaction  of such claim or claims,  either by compromise or
in satisfaction of judgment.  No such person shall be indemnified against, or be
reimbursed for any expense or payments incurred in connection with, any claim or
liability  established to have arisen out of his own wilful  misconduct or gross
negligence.

   The right of indemnification  hereinabove provided for shall not be exclusive
of any right to which any Director or officer of the  Corporation  may otherwise
be entitled by law.

ITEM 16. EXHIBITS

   The following  exhibits are filed herewith or  incorporated by reference as a
part of this Registration Statement:

   4.01  Form of Common Stock certificate (previously filed as an exhibit to the
         Company's registration statement on Form S-4, Registration No.
         33-93058, and incorporated herein by reference)
   5.01  Opinion of Brown & Bain, P.A.
   23.01 Consent of Brown & Bain, P.A. (included in Exhibit 5.01)
   23.02 Consent of Wilber & Townshend
   24.01 Power of Attorney (Filed in previous filing of Form S-3 on page II-4)



ITEM 17. UNDERTAKINGS

   (a)   The undersigned Company hereby undertakes:

         (1)   To file,  during  any  period in which  offers or sales are being
               made  of  the  securities  registered  hereby,  a  post-effective
               amendment to this registration statement:

               (i)   To include any prospectus required by section 10(a)(3) of
                     the Securities Act;

   
               (ii)  To reflect in the prospectus any facts or events arising
                     after the effective date of this registration statement 
                     (or the most recent post-effective amendment thereof)which,
                     individually or in the aggregate, represent a fundamental
                     change in the information set forth in this registration
                     statement.  Notwithstanding the foregoing, any increase or
                     decrease in volume of securities offered (if the total 
                     dollar value of securities offered would not exceed that 
                     which was registered) and any deviation from the low or
                     high end of the estimated maximum offering range may be
                     reflected in the form of prospectus filed with the
                     Commission pursuant to Rule 42(b) if, in the aggregate, the
                     changes in volume and price represent no more than a 20%
                     change in the maximum aggregate offering price set

                                     II-2

<PAGE>


                     forth in the "Calculation of Registration Fee" table in the
                     effective registration statement;

               (iii) To include any  material  information  with  respect to the
                     plan  of  distribution  not  previously  disclosed  in  the
                     registration  statement  or any  material  change  to  such
                     information in the registration statement;

               provided,  however,  that  (i)  and  (ii)  do  not  apply  if the
               registration  statement  is on  Form  S-3,  and  the  information
               required  to  be  included  in  a  post-effective   amendment  is
               contained in periodic reports filed by the registrant pursuant to
               section  13 or  section  14(d)  of  the  Exchange  Act  that  are
               incorporated by reference in the registration statement.

         (2)   That,  for the purpose of  determining  any  liability  under the
               Securities  Act,  each  such  post-effective  amendment  shall be
               deemed  to  be a  new  registration  statement  relating  to  the
               securities  offered therein,  and the offering of such securities
               shall be deemed to be the initial bona fide offering thereof.

         (3)   To  remove  from   registration  by  means  of  a  post-effective
               amendment any of the  securities  being  registered  which remain
               unsold at the termination of the offering.

   (b)   The undersigned Company hereby undertakes:

               That  for  purposes  of  determining   any  liability  under  the
         Securities Act, each filing of the registrant's  annual report pursuant
         to  section  13(a) or section  15(d) of the  Exchange  Act (and,  where
         applicable,  each filing of an employee  benefit  plan's  annual report
         pursuant to section 15(d) of the Exchange Act) that is  incorporated by
         reference  in the  registration  statement  shall be deemed to be a new
         registration  statement relating to the securities offered therein, and
         the offering of such  securities at that time shall be deemed to be the
         initial bona fide offering thereof.

   (e)   The undersigned Company hereby undertakes:

               To deliver or cause to be delivered with the prospectus,  to each
         person to whom the  prospectus  is sent or  given,  the  latest  annual
         report to security  holders  that is  incorporated  by reference in the
         prospectus and furnished  pursuant to and meeting the  requirements  of
         Rule 14a-3 or Rule 14c-3 under the Exchange  Act;  and,  where  interim
         financial  information  required  to  be  presented  by  Article  3  of
         Regulation  S-X are not set forth in the  prospectus,  to  deliver,  or
         cause to be delivered to each person to whom the  prospectus is sent or
         given, the latest quarterly report that is specifically incorporated by
         reference  in  the   prospectus  to  provide  such  interim   financial
         information.

   (h)   Insofar as indemnification for liabilities arising under the Securities
         Act may be permitted to directors, officers and controlling persons of
         the Company pursuant to the foregoing provisions, or otherwise, the
         Company has been advised that in the opinion of the Commission such 
         indemnification is against public policy as expressed in the Securities
         Act and is, therefore, unenforceable.  In the event that a claim for
         indemnification against such liabilities (other than the payment by the
         Company of expenses incurred or paid by a director, officer or 
         controlling person of the Company in the successful defense of any
         action, suit or proceeding) is asserted by such director, officer or 
         controlling person in connection with the securities being registered,
         the Company will, unless in the opinion of its counsel the matter has 
         been settled by controlling precedent, submit to a court of appropriate
         jurisdiction the question whether such indemnification by it is against
         public policy as expressed in the Securities Act and will be governed 
         by the final adjudication of such issue.




                                     II-3

<PAGE>



   Pursuant to the  requirements  of the  Securities Act of 1933, the registrant
certifies  that it has  reasonable  grounds  to  believe  that it meets  all the
requirements  for  filing  of Form S-3 and has  duly  caused  this  Registration
Statement  to be  signed  on  its  behalf  by  the  undersigned,  hereunto  duly
authorized in the City of Grand Rapids, State of Michigan, on May 29, 1996.

                                       INTELLIGENT DECISION SYSTEMS, INC.


                                       By: /s/ Mark Babin
                                           Mark A. Babin
                                           President and Chief Executive Officer

                             

   Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed below by the following persons of Intelligent Decision
Systems, Inc. in the capacities and on the date indicated.

   Signature                     Title                         Date


    /s/ Mark A. Babin      President, Chief Executive Officer, May 30, 1996
   Mark A. Babin           Chief Financial Officer (Principal
                           Executive and Accounting Officer)
                           and Director



   *                       Secretary, Treasurer and Director   May 30, 1996
   James M. Keller, Jr.




   *                        Director                           May 30, 1996
   Robert B. Hyte




  


      *By /s/ Mark A. Babin
       Mark A. Babin
       Attorney-in-Fact


Mark A. Babin,  by signing his name  hereto,  does hereby sign this  document on
behalf of each of the persons  indicated  above,  pursuant to powers of attorney
duly executed by such persons, which were filed with the Securities and Exchange
Commission on May 10, 1996, as part of this Registration Statement.


                                     II-4

<PAGE>


                              INDEX TO EXHIBITS



Exhibit No.    Exhibit                                             Sequentially
                                                                       Numbered
                                                                       Page

4.01*          Form of Common Stock Certificate of IDS

5.01           Opinion of Brown & Bain, P.C. counsel to IDS as to
               legality of securities being registered

23.01          Consent of Brown & Bain, P.A. (included in exhibit 5.01)

23.02          Consent of Wilber & Townshend

24.01**        Power of Attorney

































*  Filed as an exhibit to the Company's Registration Statement of Form S 4, 
   Registration No. 33-93058 and incorporated herein by reference.

** Filed in previous filing of Form S-3 on page II-4.


                                     II-5





                                  BROWN & BAIN
                           A PROFESSIONAL ASSOCIATION
                           2901 NORTH CENTRAL AVENUE
                             PHOENIX, AZ 85012-2788
                                 (602) 351-8000


                                    May 29, 1996


Ladies and Gentlemen:

     We have acted as counsel to Intelligent Decision Systems,  Inc., a Delaware
corporation  (the "Company"),  in connection with its Registration  Statement on
Form S-3 (the  "Registration  Statement") filed under the Securities Act of 1933
relating to the registration of 1,964,154 shares of its common stock,  $.001 par
value (the "Shares"),  on behalf of the Selling Stockholders identified therein.
Capitalized  terms  used  without  definition  herein  shall  have the  meanings
ascribed to such terms in the Registration  Statement.

     In that connection,  wehave examined such documents,  corporate records and
other  instruments as we have deemed  necessary or  appropriate  for purposes of
this opinion,  including the Restated Certificate of Incorporation and Bylaws of
the Company.

     Based upon the foregoing,  we are of the opinion  that:

     1. The Company is a corporation  duly organized and validly  existing under
the laws of the State of Delaware.

     2. The  Shares,  when issued and sold in  accordance  with the terms of the
Warrants, will be validly issued, fully paid and nonassessable.

     We  hereby  consent  to the  use  of  this  opinion  as an  exhibit  to the
Registration Statement.


                                                Very truly yours,

                                                  

                                              /s/BROWN & BAIN, P.A.


Intelligent Decision Systems, Inc.
  2025 East Beltline Avenue SE, Suite 400
    Grand Rapids, MI 49546

B&B:shj 

                                  EXHIBIT 5.01

                              WILBER & TOWNSHEND
                           A PROFESSIONAL CORPORATION
                          CERTIFIED PUBLIC ACCOUNTANTS
                                 465 Baldwin St.
                                Jenison, MI 49428






                         CONSENT OF INDEPENDENT AUDITORS



     We consent  to the use of our names as  experts  as found in the  "Experts"
section on page 13 in the Amendment No. 1 to the Form S-3 registration statement
of Intelligent Decision Systems, Inc.

         Certain  financial  statements  of Digital  Sciences  Incorporated  and
         Resource   Finance  Group  Ltd.   Incorporated  by  reference  in  this
         Prospectus  from the  company's  Form S-4 have been audited by Wilber &
         Townshend P.C., independent certified public accountants,  as indicated
         in their reports with respect there to, and included herein in reliance
         upon  authority of said firm as experts in auditing and  accounting  in
         giving said reports.



/S/Wilber & Townshend



May 29, 1996




                                 EXHIBIT 23.01




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission